key: cord-0984966-au1afn2w authors: Li, Yi; Liu, Tong; Tse, Gary; Wu, Mingxiang; Jiang, Jingjing; Liu, Ming; Tao, Liang title: Electrocardiograhic characteristics in patients with coronavirus infection: A single‐center observational study date: 2020-09-20 journal: Ann Noninvasive Electrocardiol DOI: 10.1111/anec.12805 sha: 3646ee9f2af868973c071866bc3e3b591e861cef doc_id: 984966 cord_uid: au1afn2w BACKGROUND: A global outbreak of coronavirus disease (COVID‐19), caused by severe acute respiratory coronavirus 2 (SARS‐CoV‐2), has emerged since December 2019, in Wuhan, China. However, electrocardiograhic (ECG) manifestations of patients with COVID‐19 have not been fully described. We aim to investigate ECG characteristics in COVID‐19 patients and risk factors of intensive care unit (ICU) admission. METHODS: This retrospective observational study included the patients with COVID‐19 at the Wuhan Asia General hospital between February 10, and 26, 2020. Demographic, clinical, and ECG characteristics were collected, and comparisons were made between the ICU and non‐ICU admission groups. Logistic regression was used to identify risk factors of ICU admission. RESULTS: Among 135 included patients (median age: 64 years [interquartile range: 48–72]), ST‐T abnormalities (40%) were the most common ECG feature, followed by arrhythmias (38%). Cardiovascular disease (CVD) was presented in 48% of the patients. Six (4.4%) died during hospitalization, and 23 (17.0%) were admitted to the ICU. Compared with non‐ICU group, the ICU group showed higher heart rate (p = .019) and P‐wave duration (p = .039) and was more frequently associated with CVD (p < .001), ST‐T abnormalities (p = .007), arrhythmias (p = .003), QTc interval prolongation (p = .003), and pathological Q waves (p < .001). Twenty‐seven patients were re‐examined ECG during admission, and 17 of them presented new findings compared with their initial ECG presentations. ST‐T abnormalities (p = .040) and history of CVD (p = .0047) were associated with increased risk of ICU hospitalization. CONCLUSIONS: COVID‐19 is frequently related to cardiovascular manifestations including ECG abnormalities and cardiovascular comorbidities. ST‐T abnormalities and CVD at admission were associated with increased odds of ICU admission. Extensive anterior wall (V1-V6, I, aVL) Categorical variables were depicted as frequency rates with per- with COVID-19, followed by total arrhythmias (37.8%) and left atrial abnormality (14.8%). Two patients with acute myocarditis developed third-degree atrioventricular block (Figure 1a) , and one patient with coronary heart disease presented second-degree type I atrioventricular block (Figure 1b) . Five patients were admitted with ST-segment elevation, which was later diagnosed as acute p < .001), as well as arrhythmias (Table 2 ). During hospitalization, 27 patients were re-examined ECG and 17 of them presented new findings compared with their initial ECG results (Table 3) . ST-T abnormalities (5/17), atrial fibrillation (3/17) and left ventricular hypertrophy (3/17) were the three most common emerging ECG changes ( Figure 3 ). The initial ECG abnormalities of 4 patients were resolved in re-examination. After the procedure elaborated earlier, a history of CVD, cardiac ar- (Table 4 ). This retrospective study revealed the ECG characteristics and risk factors of ICU admission in patients with COVID-19. Previous studies have confirmed that SARS-CoV can cause the ECG abnormalities in both animals and humans (Alexander et al., 1999; Yu et al., 2006) . As a virus homologous to SARS-CoV, SARS-CoV-2 was also found to be potentially arrhythmogenic. Wang et al. showed 16.7% (23/138) of COVID-19 patients combined with arrhythmias and were more common in the ICU group (44.4% vs. 6.9%, p < .001) . However, comprehensive investigations on the ECG characteristics in patients with are still sparse. In our study, we found that only 25% of COVID-19 patients presented generally normal ECG and ST-T abnormalities were the most prominent ECG manifestation among the patients with COVID-19. The ST-segment elevation in COVID-19 patients is mainly due to obstructive/nonobstructive coronary artery diseases, myocarditis, pericarditis, or stress cardiomyopathy (Dehghani et al., 2020; Inciardi et al., 2020) . However, the exact reasons for the other nonspecific were more likely to be admitted to the ICU (Jain et al., 2020) . Drugs for treating COVID-19 were regarded as the main cause of QTc prolongation, and this effect may be amplified when multiple QT-prolonging drugs were used in combination. Hydroxychloroquine (HCQ), lopinavir/ritonavir, and azithromycin have been confirmed to prolong the QTc interval in patients with COVID-19 (Sacher et al., 2020) . Moreover, some inflammatory factors (TNF-α, IL-6) and electrolyte disturbance may potentially contribute to this process (Cipriani et al., 2020) . Abnormal Q wave often indicated myocardial necrosis or stun, which may be caused by myocarditis and were associated with a poor prognosis (Buttà et al., 2020) . This partially explained why the Q waves are more common in the ICU group. As for risk factors, ST-T abnormalities and history of CVD were identified to increase the odds of ICU admission in our cohort. ST-T changes were not uncommon in patients with COVID-19 and often indicated ventricular repolarization abnormalities, which may be a potential cause of severe arrhythmias (Angeli et al., 2020) . Comprehensive assessment on drug interactions, electrolyte abnormalities, and ECG changes was imperative for the patients with CVD history on admission, because they were Recommendations for the standardization and interpretation of the electrocardiogram: part I-Ⅵ: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology ECG changes after rabbit coronavirus infection Electrocardiographic features of patients with COVID-19 pneumonia Diagnostic and prognostic role of electrocardiogram in acute myocarditis: A comprehensive review Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin Acute pneumonia and the cardiovascular system North American COVID-19 ST-segmentelevation myocardial infarction (NACMI) registry: Rationale, design, and implications Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) Enhanced electrocardiographic monitoring of patients with coronavirus disease HEART BRAKE-An unusual cardiac manifestation of Coronavirus disease 2019 (COVID-19) Cardiac arrhythmias in COVID-19 infection Cardiac and arrhythmic complications in patients with COVID-19 Guidance for cardiac electrophysiology during the coronavirus (COVID-19) pandemic from the heart rhythm society COVID-19 task force; electrophysiology section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology Potential effects of coronaviruses on the cardiovascular system: a review Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection Electrocardiogram in pneumonia World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects Cardiovascular complications of severe acute respiratory syndrome Electrocardiograhic characteristics in patients with coronavirus infection: A single-center observational study Research Ethics Commission of Wuhan Asia General Hospital (WAGHMEC-KY-2020005) . Given the retrospective review of this study, informed consent was waived. https://orcid.org/0000-0002-0783-6949Tong Liu https://orcid.org/0000-0003-0482-0738